Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism
- 1 June 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 306 (1-3) , 165-174
- https://doi.org/10.1016/0014-2999(96)00030-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Trolox Analog, U-78517F, Attenuates Hypoxic Injury in Isolated Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1994
- Evidence that Translocation of Protein Kinase C is a Key Event During Ischemic Preconditioning of Rabbit MyocardiumJournal of Molecular and Cellular Cardiology, 1994
- Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanismCardiovascular Research, 1994
- Reduction of Myocardial Infarct Size in Rabbits by RamiprilatJournal of Cardiovascular Pharmacology, 1993
- Modulation of the cell membrane expression of the kininogens regulates the rate of bradykinin delivery to cellsTrends in Cardiovascular Medicine, 1992
- Enalapril Increases Cardiac RefractorinessJournal of Cardiovascular Pharmacology, 1992
- Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.Hypertension, 1991
- The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogsCardiovascular Drugs and Therapy, 1990
- Captopril and ramiprilat protect against free radical injury in isolated working rat heartsJournal of Molecular and Cellular Cardiology, 1989
- Angiotensin metabolism by cultured human vascular endothelial and smooth muscle cellsMicrovascular Research, 1979